Rather ironic that many praised the company for their ambitions not for the shareholders, but for the development of a life-changing drug for hundreds of thousands, if not eventually millions of people. Now it's getting slapped because the cap raise wasn't available for retail participation?
Surely such a milestone is celebrated, rather individuals are finding the pessimism in progression?
They've secured essential funding which can be leveraged for exponential development in the year to come.
Have some conviction in your investments...
cheers
Ann: Argenica Successfully Completes $12.0m Placement, page-15
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
0.015(1.81%) |
Mkt cap ! $103.2M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.0¢ | 81.0¢ | $207.3K | 248.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2179 | 83.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.0¢ | 12749 | 2 |
View Market Depth
| Last trade - 15.42pm 24/06/2024 (20 minute delay) ? |
| AGN (ASX) Chart |